Preview

Russian Ophthalmological Journal

Advanced search

Contrast sensitivity and photostress recovery time in diabetics with and without diabetic retinopathy

https://doi.org/10.21516/2072-0076-2025-18-4-62-67

Abstract

Diabetes mellitus (DM) is a major public health concern and a leading cause of diabetic retinopathy (DR), a condition that can lead to vision impairment and blindness. Early detection of retinal changes is essential in preventing vision loss.

Purpose. This study investigates the relationship between photo-stress recovery time (PSRT) and contrast sensitivity (CS) in diabetic patients with and without DR compared to healthy controls.

Material and methods. A hospital-based comparative cross-sectional study was conducted at Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan. A total of 60 participants (age range: 40–75 years) were included, comprising 40 diabetic individuals (20 with DR and 20 without DR) and 20 healthy controls. Visual acuity, CS (using the Pelli — Robson chart), and PSRT (using a direct ophthalmoscope) were assessed. The correlation between DR and PSRT/CS was analyzed using the Spearman’s correlation test, with a significance level set at p < 0.05.

Results. The study found significantly lower CS and prolonged PSRT in diabetic individuals compared to controls (p < 0.05). Diabetic individuals with DR showed the most significant delay in PSRT. A weak negative correlation was observed between CS and DR, and a moderate positive correlation was found between PSRT and DR (p < 0.05).

Conclusions. PSRT is significantly prolonged in diabetic patients, particularly those with DR, compared to non-diabetic controls. The results suggest that PSRT could serve as a reliable and simple clinical tool for early detection of DR, potentially aiding in the prevention of vision loss. Further studies with larger sample sizes are needed to explore mechanisms and therapeutic interventions to improve PSRT and CS in diabetic retinopathy patients.

About the Authors

F. Hussain
Pakistan Institute of Ophthalmology, Al-Shifa Trust Eye Hospital Rawalpindi
Pakistan

Faiza Hussain — clinical optometrist

Rawalpindi, 4600



M. Firdous
Pakistan Institute of Ophthalmology, Al-Shifa Trust Eye Hospital Rawalpindi
Pakistan

Maryam Firdous — Assistant Professor (Ph.D scholar)

Rawalpindi, 4600



S. Ullah
Pakistan Institute of Ophthalmology, Al-Shifa Trust Eye Hospital Rawalpindi
Pakistan

Saif Ullah — Assistant Professor of Optometry (Ph.D scholar)

Rawalpindi, 4600



S. Qayyum
Pakistan Institute of Ophthalmology, Al-Shifa Trust Eye Hospital Rawalpindi
Pakistan

Sadaf Qayyum — assistant professor

Rawalpindi, 4600



M. Shah
KRL Hospital
Pakistan

Mutahir Shah — consultant optometrist

Muhammad Tufail Niazi Rd, G-9 Mauve Area G 9/1 G-9, Islamabad, 44000



F. Ullah Khan
Pakistan Institute of Ophthalmology, Al-Shifa Trust Eye Hospital Rawalpindi
Pakistan

Faheem Ullah Khan — consultant ophthalmologist

Rawalpindi, 4600



References

1. Yan Y, Wu T, Zhang M, et al. Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population. BMC Public Health. 2022 Jul 19; 22 (1): 1382. doi: 10.1186/s12889-022-13759-9

2. Vallianou NG, Geladari EV, Kounatidis D, et al. Diabetes mellitus in the era of climate change. Diabetes Metab. 2021 Jul; 47 (4): 101205. doi: 10.1016/j.diabet.2020.10.003

3. Aamir AH, Ul-Haq Z, Mahar SA, et al. Diabetes prevalence survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ open. 2019 Feb 1; 9 (2): e025300.

4. Haw JS, Shah M, Turbow S, et al. Diabetes complications in racial and ethnic minority populations in the USA. Curr Diab Rep. 2021 Jan 9; 21 (1): 2. doi: 10.1007/s11892-020-01369-x

5. Kropp M, Golubnitschaja O, Mazurakova A, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications — risks and mitigation. Epma Journal. 2023 Feb 13; 14 (1): 21–42. doi: 10.1007/s13167-023-00314-8

6. Shrestha A, Dahal M. Comparing and evaluating photo stress recovery time in diabetic and normal population. Acta Scientific Ophthalmology. 2021; 4 (6): 16–20. https://actascientific.com/ASOP/pdf/ASOP-04-0321.pdf

7. Malik SR, Singh G, Sood GC, et al. Macular function tests with special reference to photostress test. Indian Journal of Ophthalmology. 1971 Sep; 19 (3): 93–101. PMID: 15744978.

8. Safi S, Rahimi A, Raeesi A, et al. Contrast sensitivity to spatial gratings in moderate and dim light conditions in patients with diabetes in the absence of diabetic retinopathy. BMJ Open Diabetes Res Care. 2017 Aug 8; 5 (1): e000408. doi: 10.1136/bmjdrc-2017-000408

9. Firdous M, Masud H, Sharif H. Impact of early non-proliferative diabetic retinopathy on contrast sensitivity. Al-Shifa Journal of Ophthalmology. 2019; 15 (1): 21–9. https://alshifaeye.org/assets/downloads/research-centre/AlShifa-Annual-Research-Report-2019.pdf

10. Chande PK, Raman R, John P, et al. Contrast-sensitivity function and photo stress–recovery time in prediabetes. Clin Optom (Auckl). 2020 Sep 18; 12: 151–5. doi: 10.2147/OPTO.S259397

11. Pramanik S, Chowdhury S, Ganguly U, et al. Visual contrast sensitivity could be an early marker of diabetic retinopathy. Heliyon. 2020 Oct 26; 6 (10): e05336. doi: 10.1016/j.heliyon.2020.e05336

12. Sooryanarayana SP, Hairol MI. Contrast sensitivity, color discrimination and visual acuity as risk factors for visual dysfunction in non-proliferative diabetic retinopathy. Med & Health. Aug 2024; 19 (2): 560–72. https://doi.org/10.17576/MH.2024.1902.16

13. Ubani UA, Ihesiulor CG, Okore NE, et al. Photo stress recovery time variations in common posterior segment ocular diseases. Acta Scientific Ophthalmology. 2022 Jul; 5 (7): 26–33. https://actascientific.com/ASOP/pdf/ASOP-05-0535.pdf

14. Maqsood S. Comparison of photostress recovery time in diabetic patients and emmetrope. Journal of Health and Rehabilitation Research. 2024 Jun 4; 4. https://doi.org/10.61919/jhrr.v4iICIC1.1063

15. Baptista AMG, Sousa RARC, Rocha FASQ, et al. The macular photostress test in diabetes, glaucoma, and cataract. Proc. of the SPIE. 2013; 8785, id. 8785FW. doi: 10.1117/12.2026235

16. Loughman J, Ratzlaff M, Foerg B, Connell P. Suitability and repeatability of a photostress recovery test device, the macular degeneration detector (MDD-2), for diabetes and diabetic retinopathy assessment. Retina. May; 34 (5): 1006–13. doi: 10.1097/IAE.0000000000000021

17. Glaser JS, Savino PJ, Sumers KD, McDonald SA, Knighton RW. The photostress recovery test in the clinical assessment of visual function. American Journal of Ophthalmology. 1977 Feb 1; 83 (2): 255–60. doi: 10.1016/0002-9394(77)90624-9

18. Grott R, Chung S. Photostress recovery time as assessed using high-and lowcontrast letters. Poster 117. Optometry and Vision Science. 2001 Dec 1; 78 (12): 98. doi: 10.1097/00006324-200112001-00145


Review

For citations:


Hussain F., Firdous M., Ullah S., Qayyum S., Shah M., Ullah Khan F. Contrast sensitivity and photostress recovery time in diabetics with and without diabetic retinopathy. Russian Ophthalmological Journal. 2025;18(4):62-67. https://doi.org/10.21516/2072-0076-2025-18-4-62-67

Views: 23


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-0076 (Print)
ISSN 2587-5760 (Online)